tiprankstipranks
SAGE Therapeutics (SAGE)
NASDAQ:SAGE
Holding SAGE?
Track your performance easily

SAGE Therapeutics (SAGE) Financial Statements

898 Followers

SAGE Therapeutics Financial Overview

SAGE Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.578; its P/E ratio is -0.98; SAGE Therapeutics is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $-1.53. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 11.87M$ 8.65M$ 2.72M$ 2.47M$ 3.29M
Gross Profit$ 11.87M$ 8.65M$ 2.72M$ 2.47M$ 3.29M
EBIT$ -93.55M$ -102.85M$ -201.63M$ -160.32M$ -146.60M
EBITDA$ -93.30M$ -102.54M$ -201.30M$ -159.99M$ -146.28M
Net Income Common Stockholders$ -93.55M$ -101.45M$ -201.63M$ -160.12M$ -146.83M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 569.15M$ 646.79M$ 876.05M$ 1.00B$ 1.13B
Total Assets$ 622.43M$ 697.11M$ 949.66M$ 1.08B$ 1.22B
Total Debt$ 10.27M$ 1.41M$ 6.97M$ 8.73M$ 10.45M
Net Debt$ -558.88M$ -645.38M$ -869.09M$ -993.89M$ -1.12B
Total Liabilities$ 70.60M$ 69.04M$ 133.00M$ 97.91M$ 87.56M
Stockholders Equity$ 551.84M$ 628.06M$ 816.66M$ 984.38M$ 1.13B
Cash Flow-
Free Cash Flow$ -82.36M$ -80.44M$ -136.19M$ -131.63M$ -153.91M
Operating Cash Flow$ -82.36M$ -80.44M$ -135.87M$ -131.52M$ -153.68M
Investing Cash Flow$ 81.05M$ -386.00K$ 160.39M$ 45.59M$ 194.87M
Financing Cash Flow$ 1.04M$ 8.07M$ 2.77M$ 847.00K$ 2.67M
Currency in USD

SAGE Therapeutics Earnings and Revenue History

SAGE Therapeutics Debt to Assets

SAGE Therapeutics Cash Flow

SAGE Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis